Jazz Pharmaceuticals's total assets for Q3 2024 were $12.26B, an increase of 7.87% from the previous quarter. JAZZ total liabilities were $8.09B for the fiscal quarter, a 6.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.